BACKGROUND: In low-renin hypertension (LRH), serum aldosterone levels are higher in those subjects with primary aldosteronism and may be lower in those with non-aldosterone mineralocorticoid excess or primary renal sodium retention. We investigated the hypothesis that the frequency distribution of aldosterone in LRH is bimodal. METHODS: Of the 3,532 attendees at the sixth examination cycle of the Framingham Offspring Study, 1,831 were included in this cross-sectional analysis after we excluded those with conditions or taking medications such as antihypertensive drugs that might affect renin or aldosterone. RESULTS: Three hundred three subjects (17%) had untreated hypertension (SBP ≥140 mm Hg or DBP ≥90 mm Hg). LRH, defined as plasma renin ≤5 mU/L, was present in 93 of those 303 hypertensive subjects (31%). Aldosterone values were adjusted statistically for age, sex, and the urinary sodium/creatinine ratio. In the subjects with LRH, the adjusted aldosterone distribution was bimodal (dip test for unimodality, P = 0.008). The adjusted aldosterone distribution was unimodal in the normal subjects (P = 0.98) and in the hypertensive subjects with normal plasma renin (P = 0.94). CONCLUSIONS: In this community-based sample of white subjects, those with low-renin hypertension had a bimodal adjusted aldosterone distribution. Subjects with normal-renin hypertension and subjects with normal blood pressure had unimodal adjusted aldosterone distributions. These findings suggest 2 pathophysiological variants of LRH, one that is aldosterone-dependent and one that is non-aldosterone-dependent.
BACKGROUND: In low-reninhypertension (LRH), serum aldosterone levels are higher in those subjects with primary aldosteronism and may be lower in those with non-aldosterone mineralocorticoid excess or primary renal sodium retention. We investigated the hypothesis that the frequency distribution of aldosterone in LRH is bimodal. METHODS: Of the 3,532 attendees at the sixth examination cycle of the Framingham Offspring Study, 1,831 were included in this cross-sectional analysis after we excluded those with conditions or taking medications such as antihypertensive drugs that might affect renin or aldosterone. RESULTS: Three hundred three subjects (17%) had untreated hypertension (SBP ≥140 mm Hg or DBP ≥90 mm Hg). LRH, defined as plasma renin ≤5 mU/L, was present in 93 of those 303 hypertensive subjects (31%). Aldosterone values were adjusted statistically for age, sex, and the urinary sodium/creatinine ratio. In the subjects with LRH, the adjusted aldosterone distribution was bimodal (dip test for unimodality, P = 0.008). The adjusted aldosterone distribution was unimodal in the normal subjects (P = 0.98) and in the hypertensive subjects with normal plasma renin (P = 0.94). CONCLUSIONS: In this community-based sample of white subjects, those with low-reninhypertension had a bimodal adjusted aldosterone distribution. Subjects with normal-reninhypertension and subjects with normal blood pressure had unimodal adjusted aldosterone distributions. These findings suggest 2 pathophysiological variants of LRH, one that is aldosterone-dependent and one that is non-aldosterone-dependent.
Authors: Richard J Johnson; Jaime Herrera-Acosta; George F Schreiner; Bernardo Rodriguez-Iturbe Journal: N Engl J Med Date: 2002-03-21 Impact factor: 91.245
Authors: E Lovati; P Ferrari; B Dick; K Jostarndt; B M Frey; F J Frey; U Schorr; A M Sharma Journal: J Clin Endocrinol Metab Date: 1999-10 Impact factor: 5.958
Authors: Cristian A Carvajal; Damián G Romero; Lorena M Mosso; Alexis A González; Carmen Campino; Joaquín Montero; Carlos E Fardella Journal: J Hypertens Date: 2005-01 Impact factor: 4.844
Authors: R C Wilson; S Dave-Sharma; J Q Wei; V R Obeyesekere; K Li; P Ferrari; Z S Krozowski; C H Shackleton; L Bradlow; T Wiens; M I New Journal: Proc Natl Acad Sci U S A Date: 1998-08-18 Impact factor: 11.205
Authors: Jana Henschkowski; Andreas E Stuck; Brigitte M Frey; Gerhard Gillmann; Bernhard Dick; Felix J Frey; Markus G Mohaupt Journal: Am J Hypertens Date: 2008-04-03 Impact factor: 2.689
Authors: Charlotte Andersson; Andrew D Johnson; Emelia J Benjamin; Daniel Levy; Ramachandran S Vasan Journal: Nat Rev Cardiol Date: 2019-11 Impact factor: 32.419
Authors: Jenifer M Brown; Cassianne Robinson-Cohen; Miguel Angel Luque-Fernandez; Matthew A Allison; Rene Baudrand; Joachim H Ix; Bryan Kestenbaum; Ian H de Boer; Anand Vaidya Journal: Ann Intern Med Date: 2017-10-10 Impact factor: 25.391
Authors: Joshua J Joseph; Neal K Pohlman; Songzhu Zhao; David Kline; Guy Brock; Justin B Echouffo-Tcheugui; Mario Sims; Valery S Effoe; Wen-Chih Wu; Rita R Kalyani; Gary S Wand; Bjorn Kluwe; Willa A Hsueh; Marwah Abdalla; Daichi Shimbo; Sherita H Golden Journal: Circulation Date: 2021-02-19 Impact factor: 39.918
Authors: J Martinez; C Kellogg; M C Iazbik; C G Couto; B M Pressler; T M Hoepf; M J Radin Journal: J Vet Intern Med Date: 2017-05-09 Impact factor: 3.333